文献速递临床试验与 GCP医学人工智能与信息学

数字干预对慢性病成人心理健康症状的效果:三臂随机对照试验

Effect of a digital intervention on mental health symptoms in adults with chronic conditions: A three-arm randomized controlled trial.
PubMed 文献 · PLoS Med · 2026-08-20

本研究为三臂平行组开放标签随机对照试验,2023年2月至2024年12月在线招募13个国家825名自报慢性病成人,随机分为等待对照组、自助数字程序eMPower组及eMPower+人工支持组。主要比较eMPower+人工支持组与对照组12周HADS总分变化,结果显示干预组改善2.9分(95%CI 2.0-3.8,p<0.001),自助组亦改善2.6分(95%CI 1.8-3.5,p<0.001),两干预组间无显著差异。

要点

  • eMPower+人工支持较常规护理显著改善HADS总分2.9分(95%CI 2.0-3.8)。
  • 自助eMPower组亦显著改善HADS总分2.6分(95%CI 1.8-3.5)。
  • 两干预组间所有结局均无显著差异(p>0.05),无干预相关不良事件。

核心结论

  • 含人工支持的多组分数字干预较常规护理显著降低慢性病成人焦虑抑郁症状。
  • 探索性分析中自助与人工支持交付效果相当,提示可扩展低资源实施。

研究设计与样本

  • 三臂平行组开放标签随机对照试验,2023年2月至2024年12月在线招募与交付,覆盖13个国家。
  • 825名≥18岁自报慢性病且可上网成人,按1:1:1随机分为等待对照组(n=274)、自助eMPower组(n=275)和eMPower+人工支持组(n=276)。
  • 主要结局为基线至12周HADS总分变化,比较eMPower+人工支持组与对照组,调整基线评分、慢性病类型、年龄和性别。

主要发现

  • eMPower+人工支持组较对照组HADS总分改善2.9分(95%CI 2.0-3.8;p<0.001)。
  • 自助eMPower组较对照组HADS总分改善2.6分(95%CI 1.8-3.5;p<0.001)。
  • 两干预组间所有结局均无显著差异(所有p>0.05)。
  • 两干预组在预设次要结局上均较对照组改善,无干预相关不良事件报告。

临床怎么用

  • 多组分数字干预可考虑用于慢性病成人焦虑抑郁症状管理。
  • 自助交付与人工支持交付效果相当,可依据资源条件选择实施模式。

局限性

  • 等待对照设计无法控制非特异性干预效应。
  • 多数参与者依赖自报诊断。
  • 随访期仅12周。
  • 样本以女性及高教育程度为主,可能限制外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anxiety, depression, and fatigue affect >50% of adults across a range of chronic medical conditions, leading to reductions in quality of life. Digital symptom management interventions may address this burden, but clinical trial evidence across diverse conditions is limited, and the added value of human support remains uncertain. This study aimed to determine whether a multicomponent digital intervention, delivered with or without human support, reduces anxiety and depression compared with usual care at 12 weeks in adults with chronic medical conditions, and whether human-supported delivery outperforms self-directed delivery. METHODS AND FINDINGS: A three-arm parallel-group open-label randomized controlled trial was conducted from February 2023 to December 2024, with online recruitment and delivery across 13 countries. 825 adults (≥18 years) with self-reported chronic medical conditions and internet access were allocated by computer-generated stratified block randomization (1:1:1) to: (i) waitlist control (n = 274); (ii) eMPower, a self-directed digital program integrating video-guided movement, breathwork, and meditation practices, a psychology-based coping skills curriculum, and disease education (n = 275); or (iii) eMPower + human support consisting of weekly telephone check-ins (≤15 min) from trained nonclinicians (n = 276). The primary outcome was change in Hospital Anxiety and Depression Scale (HADS) total score from baseline to 12 weeks in the eMPower + human support arm compared with the control arm, adjusted for baseline score, chronic condition type, age, and sex. Secondary outcomes included HADS anxiety and depression subscales, fatigue (Modified Fatigue Impact Scale [MFIS]), and health-related quality of life (Short Form-12 [SF-12] mental and physical component scores and EQ-5D-5L index score). Twelve-week assessments were completed by 695 participants (84.2%). Primary outcome data were available for 222 participants in the eMPower + human support arm, 214 in the self-directed eMPower arm, and 259 in the control arm. Analyses followed the intention-to-treat principle. In the prespecified primary comparison, eMPower + human support improved HADS total score by 2.9 points (95% CI [2.0, 3.8]; p < 0.001). In prespecified exploratory analyses, the self-directed eMPower arm also significantly improved HADS total score, compared with control (mean difference 2.6 points; 95% CI [1.8, 3.5]; p < 0.001). No significant differences were observed between intervention arms for any outcome (all p > 0.05). Both intervention arms were associated with improvements across prespecified secondary outcomes compared with control. No intervention-related adverse events were reported in any arm. Key limitations include the use of a waitlist control design, which does not control for nonspecific intervention effects; reliance on self-reported diagnoses for most participants; the 12-week follow-up period; and a predominantly female and highly educated sample, which may limit generalizability. Additional registered process-oriented secondary outcomes and exploratory outcomes will be reported in companion publications. CONCLUSIONS: A multicomponent digital intervention with human support significantly reduced anxiety and depression symptoms compared with usual care in adults with chronic medical conditions. Comparable effects between self-directed and human-supported delivery in exploratory analyses highlight potential for scalable, low-resource implementation. Longer-term follow-up and cost-effectiveness analyses are warranted. Trial registration: ClinicalTrials.gov: NCT05786482.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Johnson E, Hyde A, Corrick S, et al. Effect of a digital intervention on mental health symptoms in adults with chronic conditions: A three-arm randomized controlled trial. PLoS Med. 2026. PMID: 42623335. doi:10.1371/journal.pmed.1005198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。